Envestnet Asset Management’s Rockwell Medical RMTI Stock Holding History

Envestnet Asset Management’s Portfolio RMTI Stock Details RMTI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-248	Closed	-$13K	–	4044
2022 Q1	$13K	Hold	248	–	–	﹤0.01%	3913
2021 Q4	$11K	Hold	248	–	–	﹤0.01%	3857
2021 Q3	$16K	Hold	248	–	–	﹤0.01%	3662
2021 Q2	$25K	Hold	248	–	–	﹤0.01%	3621
2021 Q1	$32K	Hold	248	–	–	﹤0.01%	3468
2020 Q4	$28K	Hold	248	–	–	﹤0.01%	3248
2020 Q3	$29K	Hold	248	–	–	﹤0.01%	3078
2020 Q2	$53K	Hold	248	–	–	﹤0.01%	3020
2020 Q1	$56K	Hold	248	–	–	﹤0.01%	2891
2019 Q4	$67K	Hold	248	–	–	﹤0.01%	3030
2019 Q3	$75K	Hold	248	–	–	﹤0.01%	2969
2019 Q2	$82K	Buy	248 +144	+138%	+$73.1K	﹤0.01%	2967
2019 Q1	$65K	Sell	104 -17	-14%	-$7.75K	﹤0.01%	2916
2018 Q4	$30K	Buy	121 +18	+17%	+$7.16K	﹤0.01%	2821
2018 Q3	$48K	Buy	+103	New	+$49.9K	﹤0.01%	1233

Other funds holding RMTI

Richmond Brothers Jackson, Michigan $150M AUM 14.02% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCA

Verdence Capital Advisors Hunt Valley, Maryland $1.72B AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

SkyOak Wealth Southfield, Michigan $546M AUM 18.14% 1-Year Est. Return

Envestnet Asset Management's RMTI Position: Q2 2022 in Review

Envestnet Asset Management sold out of Rockwell Medical (RMTI) in Q2 2022, closing a stake of 248 shares — an estimated $13K sold.

Envestnet Asset Management first reported a position in RMTI in Q3 2018 and held it in 15 quarters. The position peaked at $82K in Q2 2019. 36 funds tracked by Wall St. Rank hold RMTI as of Q2 2022.

Envestnet Asset Management reported no remaining Rockwell Medical position as of Q2 2022 after selling out during the quarter.
Envestnet Asset Management sold 248 Rockwell Medical shares in Q2 2022, an estimated $13K.
Envestnet Asset Management first reported a position in Rockwell Medical in Q3 2018 and held it in 15 quarters.
Envestnet Asset Management's Rockwell Medical position peaked at $82K in Q2 2019.
36 funds tracked by Wall St. Rank held Rockwell Medical as of Q2 2022.

Based on Envestnet Asset Management's 13F filing for Q2 2022, filed 3 Aug 2022.